Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of a Dual GLP-1/GIP Receptor Agonist (HRS9531) in Healthy Subjects-A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose (SAD and MAD) Study

被引：2
|
作者：
He, Kun
Wei, Fang
Chen, Hong
Zhang, Yanyan
Sheng, Zhen
Wen, Qing
机构：
来源：
DIABETES | 2023年 / 72卷
关键词：
D O I：
10.2337/db23-763-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
763-P
引用
收藏
页数：2
相关论文
共 50 条
  • [41] A Randomized, Placebo-Controlled, Double-Blind Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Repeated Doses of Mirogabalin in Healthy Asian Volunteers
    Jansen, Mendel
    Warrington, Steven
    Dishy, Victor
    Ohwada, Shoichi
    Johnson, Lisa
    Brown, Karen
    Ishizuka, Hitoshi
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2018, 7 (06): : 661 - 669
  • [42] A RANDOMIZED, SINGLE-CENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE, PHASE 1 STUDY TO EVALUATE THE SAFETY, PHARMACOKINETICS (PK), AND PHARMACODYNAMICS (PD) OF TAK-272 IN HEALTHY ADULT NON-ELDERLY AND ELDERLY MALE SUBJECTS
    Matsuno, K.
    Tanaka, S.
    Hashimoto, T.
    Nakamichi, H.
    Komura, E.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 : 265 - +
  • [43] Phase 1 Randomized, Double-Blind, Placebo-Controlled Study to Determine the Safety, Tolerability, and Pharmacokinetics of a Single Escalating Dose and Repeated Doses of CN-105 in Healthy Adult Subjects
    Guptill, Jeffrey T.
    Raja, Shruti M.
    Boakye-Agyeman, Felix
    Noveck, Robert
    Ramey, Sarah
    Tu, Tian Ming
    Laskowitz, Daniel T.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (06): : 770 - 776
  • [44] A Phase I, Randomized, Double Blind, Placebo-Controlled, Dose Escalating Study of the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of Hmpl-523 in Australian Male Healthy Subjects
    Lickliter, Jason
    Wu, Yan
    Hua, Ye
    Yuan, Irena
    Dai, Guangxiu
    Li, Xiong
    Wang, Jian
    Sai, Yang
    Sun, Zhongcui
    Pan, Angela
    Li, Jing
    Su, Weiguo
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [45] Safety, tolerability, pharmacokinetics and pharmacodynamics of a single intravenous dose of SHR-1707 in healthy adult subjects: two randomized, double-blind, single-ascending-dose, phase 1 studies
    Yang, Yaru
    Qiu, Hongyan
    Fan, Yuru
    Zhang, Qin
    Qin, Huiling
    Wu, Juan
    Zhang, Xuan
    Liu, Yueyue
    Zhou, Renpeng
    Zhang, Qian
    Ye, Zi
    Ma, Jingyue
    Xu, Ye
    Feng, Sheng
    Fei, Yue
    Li, Na
    Cui, Xiaojing
    Dong, Fangli
    Wang, Quanren
    Shen, Kai
    Shakib, Sepehr
    Williams, Jasmine
    Hu, Wei
    ALZHEIMERS RESEARCH & THERAPY, 2024, 16 (01)
  • [46] Safety, Tolerability, and Pharmacokinetics of Kukoamine B in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Phase I Study
    Zhao, Qian
    Liu, Hongzhong
    Wang, Zhenlei
    Wang, Teng
    Cui, Cheng
    Wang, Huanhuan
    Li, Lili
    Zhong, Wen
    Jiang, Ji
    Dong, Kai
    Chen, Shuai
    Jin, Chunyan
    Hu, Pei
    ADVANCES IN THERAPY, 2023, 40 (07) : 3186 - 3198
  • [47] Safety, Tolerability, and Pharmacokinetics of Kukoamine B in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Phase I Study
    Qian Zhao
    Hongzhong Liu
    Zhenlei Wang
    Teng Wang
    Cheng Cui
    Huanhuan Wang
    Lili Li
    Wen Zhong
    Ji Jiang
    Kai Dong
    Shuai Chen
    Chunyan Jin
    Pei Hu
    Advances in Therapy, 2023, 40 : 3186 - 3198
  • [48] Safety, tolerability, pharmacokinetics and pharmacodynamics of HSK31858, a novel oral dipeptidyl peptidase-1 inhibitor, in healthy volunteers: An integrated phase 1, randomized, double-blind, placebo-controlled, single- and multiple-ascending dose study
    Wang, Yuhao
    Yu, Chao
    Hu, Mengyue
    Wang, Lu
    Chen, Meixia
    Liu, Hanmo
    Wu, Nan
    Hou, Jie
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2025,
  • [49] Safety and Pharmacokinetics of HRS-2261, a P2X3 Receptor Antagonist, in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Study
    Fan, Yuru
    Zhang, Xuan
    Zhang, Qin
    Zheng, Liang
    Zhou, Renpeng
    Sun, Cheng
    Wang, Xihan
    Song, Ke
    He, Zhusheng
    Wang, Honghui
    Zhang, Qian
    Hu, Wei
    CLINICAL PHARMACOKINETICS, 2024, 63 (03) : 293 - 302
  • [50] Safety and Pharmacokinetics of HRS-2261, a P2X3 Receptor Antagonist, in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Study
    Yuru Fan
    Xuan Zhang
    Qin Zhang
    Liang Zheng
    Renpeng Zhou
    Cheng Sun
    Xihan Wang
    Ke Song
    Zhusheng He
    Honghui Wang
    Qian Zhang
    Wei Hu
    Clinical Pharmacokinetics, 2024, 63 : 293 - 302
12345